Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Agri varsity scientist gets UK travel grant for cancer genome training

Dr Subhash Verma

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya (CSKHPKV), Palampur, has earned recognition as Dr Subhash Verma, Professor in the Department of Animal Breeding and Genetics, has been awarded a prestigious UK Travel Grant. He will attend an international training programme on cancer genome analysis, organised by Wellcome Connecting Science at the Wellcome Genome Campus, Hinxton (UK), and hosted at Khon Kaen University, Thailand, from October 26–31.

Advertisement

CSKHPKV Vice Chancellor Prof Naveen Kumar congratulated Dr Verma on this achievement, praising his commitment to advancing cancer research. He expressed confidence that the specialised training will sharpen Dr Verma’s expertise while also raising the global profile of the university.

Advertisement

The programme will provide hands-on exposure to cutting-edge tools in somatic genome studies, including mutation calling, driver gene identification, mutational signature analysis and RNA deconvolution.

Dr Verma has already made important contributions to veterinary oncology. His participation in the programme is expected to strengthen cross-disciplinary research, bridging human and veterinary oncology, with implications for detecting genetic mutations associated with canine cancers.

Advertisement
Advertisement
Show comments
Advertisement